The Impact of Adjuvant Postoperative Radiation Therapy and Chemotherapy on Survival After Esophagectomy for Esophageal Carcinoma

被引:49
|
作者
Wong, Andrew T. [1 ,2 ]
Shao, Meng [1 ,2 ]
Rineer, Justin [3 ]
Lee, Anna [1 ,2 ]
Schwartz, David [1 ,2 ]
Schreiber, David [1 ,2 ]
机构
[1] Dept Vet Affairs New York Harbor Healthcare Syst, Dept Radiat Oncol, Brooklyn, NY USA
[2] Suny Downstate Med Ctr, Dept Radiat Oncol, 450 Clarkson Ave,Box 1211, Brooklyn, NY 11203 USA
[3] UF Hlth Canc Ctr Orlando Hlth, Dept Radiat Oncol, Orlando, FL USA
关键词
chemotherapy; esophageal cancer; esophagectomy; radiation therapy; SQUAMOUS-CELL CARCINOMA; THORACIC ESOPHAGUS; RANDOMIZED TRIAL; RADIOTHERAPY; SURGERY; CANCER; CHEMORADIOTHERAPY; RESECTION;
D O I
10.1097/SLA.0000000000001825
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: The objective of this study was to analyze the impact on overall survival (OS) from the addition of postoperative radiation with or without chemotherapy after esophagectomy, using a large, hospital-based dataset. Background: Previous retrospective studies have suggested an OS advantage for postoperative chemoradiation over surgery alone, although prospective data are lacking. Methods: The National Cancer Data Base was queried to select patients diagnosed with stage pT3-4Nx-0M0 or pT1-4N1-3M0 esophageal carcinoma (squamous cell or adenocarcinoma) from 1998 to 2011 treated with definitive esophagectomy +/- postoperative radiation and/or chemotherapy. OS was analyzed using the Kaplan-Meier method and compared using the log-rank test. Multivariate Cox regression analysis was used to identify covariates associated with OS. Results: There were 4893 patients selected, of whom 1153 (23.6%) received postoperative radiation. Most patients receiving radiation also received sequential/concomitant chemotherapy (89.9%). For the entire cohort, postoperative radiation was associated with a statistically significant but modest absolute improvement in survival (hazard ratio 0.77; 95% CI, 0.71-0.83; P < 0.001). On subgroup analysis, postoperative radiation was associated with improved OS for patients with node-positive disease (3-yr OS 34.3 % vs 27.8%, P < 0.001) or positive margins (3-yr OS 36.4% vs 18.0%, P < 0.001). When chemotherapy usage was incorporated, sequential chemotherapy was associated with the best survival (P < 0.001). Multivariate analysis revealed that the addition of chemotherapy to radiation therapy, whether sequentially or concurrently, was a strong prognostic factor for OS. Conclusions: In this hospital-based study, the addition of postoperative chemoradiation (either sequentially or concomitantly) after esophagectomy was associated with improved OS for patients with node-positive disease or positive margins.
引用
下载
收藏
页码:1146 / 1151
页数:6
相关论文
共 50 条
  • [21] Adjuvant Chemotherapy After Esophagectomy: Is There a Role in the Treatment of the Lymph Node Positive Thoracic Esophageal Squamous Cell Carcinoma?
    Lyu, Xiao
    Huang, Jing
    Mao, Yousheng
    Liu, Yutao
    Feng, Qinfu
    Shao, Kang
    Gao, Shugeng
    Jiang, Yong
    Wang, Jinwan
    He, Jie
    JOURNAL OF SURGICAL ONCOLOGY, 2014, 110 (07) : 864 - 868
  • [22] Prognostic nomogram for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy followed by adjuvant chemotherapy
    Duan, Jingjing
    Deng, Ting
    Ying, Guoguang
    Huang, Dingzhi
    Zhang, Haiyang
    Zhou, Likun
    Bai, Ming
    Li, Hongli
    Yang, Huimin
    Qu, Yanjun
    Wang, Xia
    Ba, Yi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 46 (04) : 336 - 343
  • [23] Impact of carcinoma in situ on survival of patients treated by adjuvant chemotherapy after cystectomy
    Soorojebally, Y.
    Surlemont, L.
    Neuzillet, Y.
    Lebret, T.
    PROGRES EN UROLOGIE, 2022, 32 (01): : 53 - 60
  • [24] Utilization of Adjuvant Chemotherapy, Radiation Therapy, or Combined Modality Therapy and the Impact on Survival for Uterine Carcinosarcoma
    Wong, A. T.
    Schwartz, D.
    Lee, A.
    Shao, M.
    Han, P. Y.
    Schreiber, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E291 - E291
  • [25] ASO Visual Abstract: Impact of Tumor Size on Survival Outcome in Esophageal Squamous Cell Carcinoma After Esophagectomy Following Neoadjuvant Chemotherapy
    Yasufumi Koterazawa
    Taro Oshikiri
    Hironobu Goto
    Takashi Kato
    Ryuichiro Sawada
    Hitoshi Harada
    Naoki Urakawa
    Hiroshi Hasegawa
    Shingo Kanaji
    Kimihiro Yamashita
    Takeru Matsuda
    Yoshihiro Kakeji
    Annals of Surgical Oncology, 2024, 31 (6) : 4018 - 4018
  • [26] Survival Study of Adjuvant Radiotherapy and Chemotherapy after Definitive Surgery of Locally Advanced Esophageal Carcinoma
    Zhu, S.
    Su, J.
    Li, J.
    Shen, W.
    Liu, Z.
    Song, C.
    Li, Y.
    Wang, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S323 - S323
  • [27] ASO Author Reflections: The Impact of Preoperative Chemotherapy on Survival After Esophagectomy in Elderly Patients with Esophageal Cancer
    Eisuke Booka
    Ryoma Haneda
    Kenjiro Ishii
    Yasuhiro Tsubosa
    Annals of Surgical Oncology, 2021, 28 : 1796 - 1797
  • [28] ASO Author Reflections: The Impact of Preoperative Chemotherapy on Survival After Esophagectomy in Elderly Patients with Esophageal Cancer
    Booka, Eisuke
    Haneda, Ryoma
    Ishii, Kenjiro
    Tsubosa, Yasuhiro
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (03) : 1796 - 1797
  • [29] DIFFERENTIAL THERAPY OF ADVANCED BLADDER CARCINOMA AND OF POSTOPERATIVE ADJUVANT CHEMOTHERAPY
    WEBER, W
    KNIPPER, W
    HUGO, K
    UROLOGE-AUSGABE A, 1977, 16 (03): : 190 - 192
  • [30] Dosimetric Predictors of Radiation Gastritis Due to Postoperative Intensity Modulated Irradiation Therapy in Patients with Esophageal Squamous Cell Carcinoma After Radical Esophagectomy
    Shen, Wen-Bin
    Wang, Yu-Fang
    Gao, Hong-Mei
    Zhu, Shu-Chai
    Li, You-Mei
    Li, Shu-Guang
    Su, Jin-Wei
    Li, Juan
    Liu, Zhi-Kun
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2019, 34 (07) : 419 - 426